Member Directory

Metabolomic Technologies Inc.

Metabolomic Technologies Inc. (MTI) is a privately held Canadian company based in Edmonton, Canada. MTI specializes in metabolomics-based diagnostics for the healthcare market. MTI’s flagship product, PolypDx™, is the first and only urine-based test with a high sensitivity for detecting adenomatous polyps, the precursor to colorectal cancer (CRC). PolypDx™ provides healthcare professionals with a new tool for early screening and detection, enabling the timely removal of polyps before they progress to colorectal cancer.